NervGen Pharma Corp. (NGEN) stock
NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.96+0.14 (+7.69%)
Close on Nov 17, 2026Market cap $156.11MP/E –Yield –
NervGen Pharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
NervGen Pharma's enterprise value was $91.88M on Nov 11, 2026, against $288.67M a year earlier. Over the last 3 years it ranged from $76.69M to $381.27M, with a median of $136.60M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $91.88M | -75.9% |
| 2025 | Dec 31, 2025 | $381.27M | +212.9% |
| 2024 | Dec 31, 2024 | $121.85M | – |
See a number that looks wrong?